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Abstract: Brochopulmonary infection in
cystic fibrosis (CF) patients is associated with
chronic progressive lung disease. The role of
host factors, such as neutrophil functions, in
the progressive pathologic processes in the
respiratory tract of these patients, is poorly
defined. Neutrophil chemotaxis is one of the
first mechanisms of host defense to become
activated after bacterial invasion has
occurred. This study was aimed to evaluate
the role of neutrophil chemotaxis in CF and
also to determine whether an acute bacterial
infection and the nutritional status can affect
neutrophil chemotaxis or not. Twelve acutely
infected and 12 clinically stable CF patients
and 10 healthy age-matched controls were
studied. Neutrophil chemotaxis and random
migration were investigated in-vitro in the
peripheral blood of the subjects by the
Boyden-chamber method and the results

Introduction
Cystic fibrosis (CF) is a genetically linked multisystem
disease, accompanied by chronic bronchopulmonary
infection and progressive lung injury. A variable period of
chronic pulmonary infection and progressive lung injury is
associated with considerable morbidity (1). Lung injury is
mainly caused by a continuous and exuberant host
inflammatory response to chronic endobronchial bacterial
infection. Once bronchopulmonary infection is
established, the single most consistently observed
abnormality in CF lung defense is the inability to eradicate
these organisms (2). In CF there is no convincing evidence
to suggest a defect in host defenses although there are
reports of individual cases of abnormality (3,4).
The combination of all the immunological
abnormalities described in CF appear to have a final
common pathway through effects on neutrophils (4).
Neutrophils play an important role in host defense
through their ability to remove pathogens and antigenic
material from affected tissues. Chemokinetic properties

were expressed as chemotactic index (CI).
The nutritional status of the cases was
evaluated as basal mass index (BMI). The CI
values in the acutely infected group were
found to be significantly lower than the
clinically stable and the healthy control
groups (p<0.05 and p<0.05, respectively).
There was no significant difference between
the clinically stable CF group and the healthy
control group (p>0.1). No significant
correlation was detected between the CI and
BMI of the two groups of CF patients
(p>0.05). The present study confirms that
neutrophil chemotaxis and random migration
are normal in clinically stable CF patients. The
decreased CI in acutely infected patients
indicates the possible role of infection itself
on neutrophil chemotaxis.
Key Words: Cystic fibrosis, neutrophils,
chemotaxis

of circulating phagocytic cells have been shown to be
important in the host response to bacterial infection (5).
The role of neutrophil functions in the progressive
pathologic processes in the respiratory tract of CF
patients is poorly defined and variable (6-10). Greater
knowledge of the host response in CF patients would be
of considerable advantage in the control of the
inflammatory processes in the lung of these cases. This
study was aimed primarily to evaluate the role of
neutrophil chemotaxis in acutely infected and in clinically
stable CF patients, and also to evaluate any possible role
of the nutritional status of CF patients on neutrophil
chemotaxis.
Material and Methods
Patients: Twelve CF patients with acute bacterial
infection, 12 CF patients without evidence of infection
(cilinically stable) and 10 healthy age-matched controls
were included into the study. The acute bacterial infection
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was diagnosed according to the presence of increased
sputum production and purulence, increased cough or
respiratory distress, fever, increased erythrocyte
sedimentation rate, increased white blood cell count and
changes in the chest X-ray. The clinically stable CF
patients were the cases who applied to the hospital for
routine monthly check-ups, without clinical and
laboratory evidence of infection. Subjects under antibiotic
or antiinflammatory therapy within the last 10 days were
excluded from the study.
Basal mass index (BMI), which is an indicator of the
nutritional status, was calculated and percentile values
were determined for each patient, according to the
standard BMI values (11) and these were correlated with
the CI values in the study groups.
Microbiology: The bacteriological evaluation of the
semiquantitative sputum cultures and smears from the
acutely infected CF patients and throat cultures from the
clinically stable CF patients was performed according to
the standard microbiological techniques (12).
Chemotaxis assay: A modified Boyden-chamber
method was used for the assessment of neutrophil (PMN)
chemotaxis and random migration (13). Peripheral blood
was collected in heparinized (10 U/ml) syringes from the
subjects. Erythrocytes were allowed to settle for 1 hour
at 37˚C and the top leucocyte rich plasma was layered
over 5 ml Ficoll-Hypaque (density=1077 g/ml, Sigma
Chemical Co., St. Louis, MO, USA) and centrifuged at 400
g for 30 min. PMN cell pellet was then washed twice, the
residual erytrocytes were lysed and the remaining PMNs
were resuspended in RPMI-1640 (Sigma Chemical Co.).
Cell count was adjusted to 5x106 cells/ml. Viability of the
PMNs was assessed by Trypan blue test. For the
asessment of random migration and chemotaxis of PMNs
the lower compartment of the Boyden-chambers was
filled with RPMI-1640 and zymosan-activated serum
(ZAS), respectively. The upper compartments were filled
with PMN suspension. The upper and lower chambers
were seperated by a nitrocellulose membrane with a
mean pore diameter of 3 µm (Millipore Corp., USA). The
chambers were incubated at 37˚C in 5-10% CO2 for 60
Bacteria isolated

Pseudomonas aeruginosa
Staphylococcus aureus
Haemophilus influenzae
Klebsiella pneumoniae
Escherichia coli
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min. The membrane was then removed and stained with
Harris haematoxylin stain. Estimation of migration was
undertaken by the leading front technique (14). The
results were expressed as chemotactic index (CI): motility
with chemoattractant (ZAS)/random migration. Each
assay was run in duplicate.
Statistical analysis: Mann-Whitney test analysis
between groups was applied for the evaluation of
statistical significance in terms of relation between
chemotaxis and presence of infection. Sperman rank
correlation test was used to determine the correlation
between CI and BMI percentile of the cases.
Results
The mean age±s.e.m. of the patients in the clinicaly
stable group was 5.36±1.20 years (range=1.14 years),
in the acutely infected group was 4.48±1.12 years (2-17
years) and in the healthy control group was 6.40±1.54
years (3-10 years). The male to female ratio was 3/9 in
the infected group, 8/4 in the stable group and 6/4 in the
control group.
The distribution of the isolated bacteria in the acutely
infected and the clinically stable CF patients is presented
on Table 1. The isolation of bacteria in the clinically stable
group was considered as “colonization” according to the
clinical evaluation of the case and microscopic evaluation
of the specimen. Pseudomonas aeruginosa was the most
frequent bacterial pathogen isolated from the acutely
infected cases (66.66%).
The chemotactic index of the circulating PMNs,
expressed as mean CI±s.e.m., from the acutely infected
CF patients (1.44±0.05) was found to be markedly
decreased when compared to that of the clinically stable
CF patients (1.83±0.12), or the age-matched controls
(1.93±0.08), (p<0.05) (Fig. 1). The CI values of the
clinically stable CF patients were not significantly different
than the values of the healthy controls (p>0.05).
Random migration of the PMNs from the acutely
infected group (38.33±2.09) was not different from that
of the clinically stable CF patients (33.74±1.42) and the

Acutely infected
group (n)

Clinically stable
group (n)

8
3
2
1
0

2
3
0
0
1

Table 1.

Distribution of bacteria isolated
from the two groups of CF
patients.
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Figure 1.

Mean
chemotactic
index±s.e.m. in acutely infected and clinically stable CF
patients and in the healthy
control group.

Table 2.

Distribution of the BMI (Basal
Mass Index) Percentiles of the
Cases in Two Groups of the CF
Patients.

3_
mean ± s.e.m.

Chemotactic index (CI) ± s.e.m.

2.5

_

2_

1.5 _

1_
0

Acutely infected
CF patients

Clinically stable
CF patients

Health control
group

BMI Percentiles (%)
25
50

Study group

5

10

Acutely infected
group (n=12)
Clinically stable
group (n=12)

2

2

1

-

2

4

75

90

4

-

3

4

1

1

healthy controls (34.72±2.88). No significant statistical
difference was observed between the random migration
values of the three groups (p>0.05).

CF include decreased lymphocyte responsiveness, defects
in opsonic activity and increased circulating immune
complexes (6).

The distribution of the BMI percentile values of the
cases in the acutely infected and clinically stable groups
was shown on Table 2. No significant correlation was
detected between the CI and BMI percentiles of the cases
in both groups (p>0.05).

Chemotaxis of PMNs is an important event in the host
defense mechanism against bacterial invasion (5). It has
been previously shown that PMN chemotaxis is variably
affected in CF. Church et al showed that PMN chemotaxis
was normal both in clinically stable and in acutely infected
CF patients (8,9). On the other hand Hill et al detected
markedly increased PMN chemotaxis in CF patients with
symptomatic pulmonary infection and also detected the
return of leukotactic activity to normal levels as active
pulmonary infection disappeared (10). Leucocyte
locomotion was found to be significantly depressed in CF
patients studied by Zielinski et al., but the relation of
acute pulmonary infection with leukocyte locomotion was
not pointed out clearly (7). Kurland et al., documented
defective chemotaxis in an infant with CF and
polymicrobial bacterial sepsis (15).

There was no significant correlation between the CI
and mean age (p>0.05) of the three groups (p>0.05).
Discussion
Most of the morbidity and mortality associated with
CF is due to chronic progressive pulmonary disease.
Several studies have suggested an association between
the severity of the pulmonary disease of CF and measures
of chronic inflammation, morbidity and mortality (2,4).
The role of the immune fucntions that contribute to the
increased incidence of infections in patients with CF has
not been clearly defined yet. The relationship of the
immune response to age, chronic malnutrition and the
basic defect in CF is not established. The immunological
abnormalities that have been described in patients with

The present study confirms that neutrophil
chemotaxis and random migration are normal in clinically
stable CF patients. Thus a primary role of a congenital
neutrophil chemotaxis defect does not appear to be likely
as also indicated in some of the previous studies (8,10).
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On the other hand in the acutely infected CF patients,
though random migration values are not significantly
different from the other two groups, the chemotaxis
index values are different significantly, indicating the
possible role of infection itself on neutrophil chemotaxis.
It has been previously shown that neutrophil chemotaxis
is decreased during the course of recurrent infections,
such as lower respiratory tract infections (16,17). It is
known that pulmonary infections in CF are associated
with chronic colonisation by bacterial pathogens and
episodes of acute debilitating exacerbations usually due to
bacteria (1,4). Thus it can be speculated that chemotactic
inhibitors may originate from the chronically colonised
foci in the airways. This also raises the possibility that
repeated infections since early infancy may have
maintained a sufficiently large antigenic mass to result in
immunologic hyporesponsiveness, such as depressed PMN
chemotaxis. The clinical and microbiological follow-up of
these acutely infected and chemotactically depressed
patients showed that they have been chronicity of the
infection may be a reason for depressed PMN chemotaxis
seen in these patients. P. aeruginosa was the most
frequently isolated bacteria in the acutely infected group.
It is known that rhamnolipid, elastase and alkaline
protease which are the products of P. aeruginosa,
decrease neutrophil chemotaxis (13), and this fact may
also explain decreased neutrophil chemotaxis in the
acutely infected CF patients in our study, as 66.66% of
the infections were due to P. aeruginosa.
It has been previously shown that malnutrition may
result in alterations in immune functions, including
polymorphonuclear leucocyte chemotaxis and killing (19).
Most of the CF patients are known to be malnourished
(2). Kurland et al reported a CF case with malnutrition

and sepsis, with a transient defect in neutrophil
chemotaxis, but were not able to clarify the role of
malnutrition on neutrophil chemotaxis (15). When BMI
values were evaluated in our patients, it was determined
that no correlation existed between the BMI and CI
values, indicating no significant effect of the nutritional
status of the caes on neutrophil chemotaxis. In fact our
CF patients did not have severe malnutrition, therefore it
is not likely to propose that nutritional status has no
effect on neutrophil chemotaxis in CF patients.
The previous studies on PMN chemotaxis in CF
patients revealed variable results. Conflicting data on the
degree of impairment of neutrophil locomotion in CF may
be explained by differences between techniques used for
assessing locomotion, or by the diverging states of
disease activity, age of patients studied and presence and
chronicity of infection.
It can be concluded that decreased neutrophil
chemotaxis may be a consequence of recurrent
respiratory infections and ineffective clearing of the
offending endobronchial microorganisms, due to
depressed neutrophil chemotaxis, may have a role in the
pathogenesis and progression of pulmonary dysfunction
in CF. Unregulated inflammation may interfere with
normal airway anatomy and function, ultimately leading
to tissue injury. These findings provide the basis for
further studies on the role of the neutrophils in the
inflammatory processes seen in CF.
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